PHARMACISTS ‘FIRED UP’ FOR SMOKING CESSATION SUPPORT
Pharmacists who provide structured smoking cessation advice make a real difference, delivering improved outcomes for individuals quitting smoking1
.
N
ow, according to research commissioned by Johnson & Johnson Consumer Health EMEA (J&J), more than half (55 per cent)2
of smokers say they want to be both tobacco and nicotine free, with four in ten (43 per cent) are looking to pharmacists to provide the advice they need on smoking cessation.4
J&J’s research - which featured 6,378 people, 1113 of whom were from the United Kingdom (UK) - revealed that consumer interest in smoking cessation is on the increase, with 28 per cent of UK smokers citing COVID-19 as the main reason for quitting.2
This is expected to continue
following advice from the WHO that evidence suggests that smoking is associated with increased severity of disease and death in hospitalised COVID-19 patients.5
Every year, around 78,000 people in the UK die from smoking-related diseases, with many more living with debilitating smoking-related illnesses.7
It’s well known that smoking increases the risk of developing more than 50 serious health conditions7
, such as causing damage to the heart
and blood circulation, thereby increasing the risk of developing a range of cardiovascular conditions. It can also cause harm to the lungs, leading to conditions such as COPD, and worsening or prolonging the symptoms of respiratory conditions such as asthma, or respiratory tract infections.
During pregnancy, smoking carries significant risk to both the mother and the unborn baby. Despite this, research suggests that more than one in ten pregnant women still smoke at the time they give birth, and while the number of women smoking while pregnant has fallen by nearly a third in the past decade, the rate of decrease has fallen in recent years.8
The good news, according to J&J’s previous research, is that more than eight out of ten pharmacists are interested in the management and treatment of smokers looking to quit.3
‘We know that community pharmacy-delivered behavioural intervention and support, together with pharmacotherapeutic advice, is invaluable for smokers wishing to quit,’ said Dr Mark Watt MD, Medical Affairs Senior Director at Johnson & Johnson Consumer Health EMEA. ‘With more
24
scottishpharmacist.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
